Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us did not even know what…
Controversial FDA official leaving drug center post in latest departure at agency
The leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs is leaving…
FDA Resubmission Path for Tab-cel Keeps Atara’s (ATRA) Regulatory Timeline Alive
medical research 7 ©Belova59 – pixabay.com Atara Biotherapeutics said the FDA outlined a potential pathway for resubmitting the…
Does FDA’s Rolling Review Of COMP360 Psilocybin Depression Therapy Change The Bull Case For COMPASS Pathways (CMPS)?
In April 2026, COMPASS Pathways announced that the FDA granted a rolling NDA review for its synthetic psilocybin…
Can Oral Ozempic and Label Expansions Revive NVO’s Near-Term Growth?
Novo Nordisk NVO is a dominant player in the GLP-1 space, marketing its semaglutide drugs under brand names Ozempic…
America’s debt problem is a health care problem
America has a spending problem. It also has a health care problem. These are not two separate crises…
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
Collection of sandflies, which can transmit river blindness Universal Images Group via Getty Images Occasionally I’ll go watch…
FDA Lists Xanax Recall. Here’s What You Need To Know
If you are taking Xanax XR, check whether your medication falls within the lot that’s being recalled. (Photo:…
LLY’s Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study
Eli Lilly and Company LLY announced that a phase III study, ACHIEVE-4, evaluating its newly approved oral GLP-1…
Why RFK Jr. backs peptides but questions vaccines
Robert F. Kennedy Jr. tends to favor health choices he sees as natural — whether that means eating…